Published in Front Cell Neurosci on September 08, 2014
MicroRNA-125b regulates microglia activation and motor neuron death in ALS. Cell Death Differ (2016) 0.80
Network-based analysis of differentially expressed genes in cerebrospinal fluid (CSF) and blood reveals new candidate genes for multiple sclerosis. PeerJ (2016) 0.77
Emerging Roles of Filopodia and Dendritic Spines in Motoneuron Plasticity during Development and Disease. Neural Plast (2015) 0.76
Clematichinenoside Serves as a Neuroprotective Agent Against Ischemic Stroke: The Synergistic Action of ERK1/2 and cPKC Pathways. Front Cell Neurosci (2016) 0.76
Global treadmilling coordinates actin turnover and controls the size of actin networks. Nat Rev Mol Cell Biol (2017) 0.75
A Stromal Cell-derived Factor 1 alpha Analogue Improves Endothelial Cell Function in Lipopolysaccharide-induced Acute Respiratory Distress Syndrome. Mol Med (2016) 0.75
Differential effects of phytotherapic preparations in the hSOD1 Drosophila melanogaster model of ALS. Sci Rep (2017) 0.75
NetDiff - Bayesian model selection for differential gene regulatory network inference. Sci Rep (2016) 0.75
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (2006) 27.96
The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev (2007) 21.13
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron (2011) 20.15
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron (2011) 18.73
Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science (2009) 12.99
ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron (2006) 7.82
Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol (2004) 6.26
Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci U S A (1997) 4.70
The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet (2001) 4.54
Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat Rev Neurosci (2009) 4.16
Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron (2013) 3.63
State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci (2013) 3.54
Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. J Cell Biol (2003) 3.40
Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell (2008) 3.34
Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum Mol Genet (2008) 2.82
Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science (2008) 2.51
SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest (2008) 2.42
NOX enzymes in the central nervous system: from signaling to disease. Antioxid Redox Signal (2009) 2.38
Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol (2011) 2.34
Axonal mRNA localization and local protein synthesis in nervous system assembly, maintenance and repair. Nat Rev Neurosci (2012) 2.27
Microglia in ALS: the good, the bad, and the resting. J Neuroimmune Pharmacol (2009) 2.22
Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature (2012) 2.08
The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice. Proc Natl Acad Sci U S A (2006) 1.90
Remote control of gene function by local translation. Cell (2014) 1.72
Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Exp Neurol (2012) 1.66
FUS-SMN protein interactions link the motor neuron diseases ALS and SMA. Cell Rep (2012) 1.50
Diverse roles of Rho family GTPases in neuronal development, survival, and death. Front Biosci (2008) 1.49
Redox modifier genes in amyotrophic lateral sclerosis in mice. J Clin Invest (2007) 1.46
TDP-43 depletion induces neuronal cell damage through dysregulation of Rho family GTPases. J Biol Chem (2009) 1.44
Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor. J Biol Chem (2004) 1.32
The microglial-motoneuron dialogue in ALS. Acta Myol (2011) 1.31
Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model. Hum Mol Genet (2010) 1.27
A Rac1/phosphatidylinositol 3-kinase/Akt3 anti-apoptotic pathway, triggered by AlsinLF, the product of the ALS2 gene, antagonizes Cu/Zn-superoxide dismutase (SOD1) mutant-induced motoneuronal cell death. J Biol Chem (2004) 1.26
Profilin, a multi-modal regulator of neuronal plasticity. Bioessays (2008) 1.21
Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality. Hum Mol Genet (2012) 1.17
The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype. Acta Neuropathol (2014) 1.13
Alsin/Rac1 signaling controls survival and growth of spinal motoneurons. Ann Neurol (2006) 1.08
The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function. Brain (2006) 1.07
Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy. BMC Med (2012) 1.05
The spinal muscular atrophy disease protein SMN is linked to the Rho-kinase pathway via profilin. Hum Mol Genet (2011) 1.04
ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN. Hum Mol Genet (2013) 1.04
Redox regulation of Ras and Rho GTPases: mechanism and function. Antioxid Redox Signal (2012) 1.02
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis. Cell Mol Life Sci (2013) 1.00
Mislocalised FUS mutants stall spliceosomal snRNPs in the cytoplasm. Neurobiol Dis (2013) 0.97
Fasudil, a rho kinase inhibitor, limits motor neuron loss in experimental models of amyotrophic lateral sclerosis. Br J Pharmacol (2013) 0.95
Diapocynin and apocynin administration fails to significantly extend survival in G93A SOD1 ALS mice. Neurobiol Dis (2011) 0.95
Amyotrophic lateral sclerosis: new insights into underlying molecular mechanisms and opportunities for therapeutic intervention. Antioxid Redox Signal (2012) 0.94
Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice. Neurobiol Aging (2013) 0.93
Alsin and SOD1(G93A) proteins regulate endosomal reactive oxygen species production by glial cells and proinflammatory pathways responsible for neurotoxicity. J Biol Chem (2011) 0.91
Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis. Glia (2013) 0.90
The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis. Front Cell Neurosci (2014) 0.90
Profilin-1 mutations are rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.90
The spinal muscular atrophy gene product regulates neurite outgrowth: importance of the C terminus. FASEB J (2007) 0.90
Mitochondrial redox signalling by p66Shc mediates ALS-like disease through Rac1 inactivation. Hum Mol Genet (2011) 0.89
The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis. J Immunol (2013) 0.88
TDP-43 regulates the mammalian spinogenesis through translational repression of Rac1. Acta Neuropathol (2012) 0.84
Rac1 selective activation improves retina ganglion cell survival and regeneration. PLoS One (2013) 0.83
Genome-wide identification of mRNAs associated with the protein SMN whose depletion decreases their axonal localization. RNA (2013) 0.82
The E. coli CNF1 as a pioneering therapy for the central nervous system diseases. Toxins (Basel) (2014) 0.79